Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator binding	JUND PER2 GATA3 PER1 NR1D1 THAP7	1.14e-05	140	72	6	GO:0001221
GeneOntologyMolecularFunction	transcription corepressor binding	PER2 PER1 NR1D1 THAP7	6.09e-05	59	72	4	GO:0001222
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2C KMT2D	3.54e-04	8	72	2	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2C KMT2D	5.66e-04	10	72	2	GO:0140999
GeneOntologyMolecularFunction	kinase binding	MLXIPL PER2 ABI2 TICAM1 ZBTB4 PER1 DNM3 TNS2 SORBS1 TESK1 ARHGAP33	6.64e-04	969	72	11	GO:0019900
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain binding	SCAF8 BRD4	6.91e-04	11	72	2	GO:0099122
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	KMT2C JUND KMT2D PER2 ABI2 TICAM1 BRD4 BCORL1 AKAP13 SORBS1 THAP7 SOS1	8.42e-04	1160	72	12	GO:0030674
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HOXB2 MLXIPL JUND KMT2D GATA3 SIX5 NR4A1 ZNF467	9.01e-04	560	72	8	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HOXB2 MLXIPL JUND KMT2D GATA3 SIX5 NR4A1 ZNF467	9.64e-04	566	72	8	GO:0001216
GeneOntologyMolecularFunction	signaling adaptor activity	ABI2 TICAM1 AKAP13 SORBS1	1.22e-03	129	72	4	GO:0035591
GeneOntologyMolecularFunction	E-box binding	GATA3 PER1 NR1D1	1.39e-03	61	72	3	GO:0070888
GeneOntologyMolecularFunction	RNA polymerase binding	PER2 SCAF8 BRD4	1.67e-03	65	72	3	GO:0070063
GeneOntologyMolecularFunction	SH3 domain binding	ABI2 ENAH DENND1A SOS1	1.78e-03	143	72	4	GO:0017124
GeneOntologyMolecularFunction	histone methyltransferase binding	PER2 GATA3	1.89e-03	18	72	2	GO:1990226
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	GARNL3 ARHGAP10 AKAP13 GMIP DENND1A ARHGAP33 SOS1	2.32e-03	507	72	7	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	GARNL3 ARHGAP10 AKAP13 GMIP DENND1A ARHGAP33 SOS1	2.32e-03	507	72	7	GO:0030695
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2C KMT2D	2.34e-03	20	72	2	GO:0042800
GeneOntologyMolecularFunction	molecular adaptor activity	KMT2C JUND KMT2D PER2 ABI2 TICAM1 BRD4 BCORL1 AKAP13 SORBS1 THAP7 SOS1	3.15e-03	1356	72	12	GO:0060090
GeneOntologyMolecularFunction	GTPase activator activity	GARNL3 ARHGAP10 GMIP ARHGAP33 SOS1	3.35e-03	279	72	5	GO:0005096
GeneOntologyMolecularFunction	histone reader activity	BRD4 THAP7	3.94e-03	26	72	2	GO:0140566
GeneOntologyMolecularFunction	transcription coactivator activity	KMT2C JUND KMT2D PER2 BRD4	4.75e-03	303	72	5	GO:0003713
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	MLXIPL JUND PER2 ZBTB4 GATA3 PER1 SIX5 NR4A1 ZNF467 NR1D1 ZNF865	4.77e-03	1244	72	11	GO:0000978
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BRD4 THAP7	5.22e-03	30	72	2	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD4 THAP7	5.57e-03	31	72	2	GO:0140033
GeneOntologyMolecularFunction	alpha-actinin binding	XIRP2 PALLD	5.57e-03	31	72	2	GO:0051393
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	MLXIPL JUND PER2 ZBTB4 GATA3 PER1 SIX5 NR4A1 ZNF467 NR1D1 ZNF865	5.60e-03	1271	72	11	GO:0000987
GeneOntologyMolecularFunction	transcription factor binding	MLXIPL JUND PER2 GATA3 PER1 NR4A1 NR1D1 THAP7	5.62e-03	753	72	8	GO:0008134
GeneOntologyCellularComponent	dendritic spine	ABI2 DNM3 NR1D1 ZNF804A ARHGAP33 SEZ6	2.17e-04	242	74	6	GO:0043197
GeneOntologyCellularComponent	neuron spine	ABI2 DNM3 NR1D1 ZNF804A ARHGAP33 SEZ6	2.42e-04	247	74	6	GO:0044309
GeneOntologyCellularComponent	contractile actin filament bundle	XIRP2 ENAH SORBS1 PALLD	5.67e-04	107	74	4	GO:0097517
GeneOntologyCellularComponent	stress fiber	XIRP2 ENAH SORBS1 PALLD	5.67e-04	107	74	4	GO:0001725
GeneOntologyCellularComponent	postsynaptic endocytic zone	DNM3 RNF216	6.66e-04	11	74	2	GO:0098843
GeneOntologyCellularComponent	actomyosin	XIRP2 ENAH SORBS1 PALLD	7.93e-04	117	74	4	GO:0042641
GeneOntologyCellularComponent	SCAR complex	ABI2 WASF3	7.97e-04	12	74	2	GO:0031209
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C KMT2D	7.97e-04	12	74	2	GO:0044666
GeneOntologyCellularComponent	actin filament bundle	XIRP2 ENAH SORBS1 PALLD	8.19e-04	118	74	4	GO:0032432
GeneOntologyCellularComponent	actin cytoskeleton	XIRP2 ABI2 ENAH AKAP13 SORBS1 ADAM8 PALLD ARHGAP33	9.66e-04	576	74	8	GO:0015629
GeneOntologyCellularComponent	nuclear protein-containing complex	KMT2C MLXIPL JUND KMT2D SF3B4 PER2 PELP1 ATXN7 SCAF8 BICRA TIPIN SF3A1 BRD4	1.00e-03	1377	74	13	GO:0140513
GeneOntologyCellularComponent	lamellipodium	ABI2 WASF3 ENAH TESK1 PALLD	1.34e-03	230	74	5	GO:0030027
GeneOntologyCellularComponent	chromatin	HOXB2 MLXIPL JUND PELP1 ATXN7 BICRA TIPIN BRD4 GATA3 SIX5 NR4A1 NR1D1 THAP7	1.92e-03	1480	74	13	GO:0000785
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2C KMT2D PELP1	2.40e-03	75	74	3	GO:0035097
HumanPheno	Large earlobe	MLXIPL KMT2D TMEM94 BICRA	1.57e-05	37	22	4	HP:0009748
HumanPheno	Radioulnar synostosis	MLXIPL SF3B4 BICRA BRD4 SOS1	1.69e-05	79	22	5	HP:0002974
HumanPheno	Atresia of the external auditory canal	KMT2D SF3B4 BRD4 SIX5	9.50e-05	58	22	4	HP:0000413
HumanPheno	Midface retrusion	KMT2C MLXIPL KMT2D SF3B4 BICRA MMP23B SOS1	1.50e-04	291	22	7	HP:0011800
HumanPheno	Gastroesophageal reflux	KMT2C MLXIPL KMT2D SZT2 TMEM94 BICRA BRD4 MMP23B TYMP	1.58e-04	517	22	9	HP:0002020
HumanPheno	Abnormal semicircular canal morphology	KMT2D SIX5 SOS1	1.71e-04	26	22	3	HP:0011380
HumanPheno	Branchial sinus	KMT2D SIX5	1.77e-04	5	22	2	HP:0100272
HumanPheno	Deviation of finger	MLXIPL KMT2D SF3B4 MOGS TMEM94 BRD4 MMP23B RNF216 SOS1	2.12e-04	537	22	9	HP:0004097
HumanPheno	Abnormal eyebrow morphology	KMT2C MLXIPL KMT2D SF3B4 SZT2 TMEM94 BICRA BRD4 MMP23B SOS1	2.22e-04	674	22	10	HP:0000534
HumanPheno	Abnormal earlobe morphology	KMT2C MLXIPL KMT2D TMEM94 BICRA	2.38e-04	137	22	5	HP:0000363
HumanPheno	Vesicoureteral reflux	KMT2C MLXIPL KMT2D BRD4 GATA3 SIX5	2.59e-04	221	22	6	HP:0000076
HumanPheno	Synostosis involving bones of the upper limbs	MLXIPL SF3B4 BICRA BRD4 SOS1	2.64e-04	140	22	5	HP:0100238
HumanPheno	Branchial cyst	KMT2D SIX5	2.64e-04	6	22	2	HP:0009796
HumanPheno	Deviation of the hand or of fingers of the hand	MLXIPL KMT2D SF3B4 MOGS TMEM94 BRD4 MMP23B RNF216 SOS1	3.09e-04	564	22	9	HP:0009484
HumanPheno	Abnormal inner ear morphology	KMT2D PCDH15 SIX5 SOS1	3.49e-04	81	22	4	HP:0011390
HumanPheno	Abnormal morphology of the vestibule of the inner ear	KMT2D SIX5 SOS1	3.51e-04	33	22	3	HP:0011376
HumanPheno	Abnormal heart valve morphology	MLXIPL KMT2D SF3B4 SZT2 TMEM94 BRD4 MMP23B CAPN15 SOS1	4.24e-04	588	22	9	HP:0001654
HumanPheno	Abnormal ureter physiology	KMT2C MLXIPL KMT2D BRD4 GATA3 SIX5	4.53e-04	245	22	6	HP:0025634
HumanPheno	Abnormality of the ulna	MLXIPL SF3B4 BICRA BRD4 SOS1	4.76e-04	159	22	5	HP:0002997
HumanPheno	Abnormal morphology of ulna	MLXIPL SF3B4 BICRA BRD4 SOS1	4.76e-04	159	22	5	HP:0040071
HumanPheno	Abnormal nipple morphology	KMT2D TMEM94 BICRA BRD4 RNF216 SOS1	5.50e-04	254	22	6	HP:0004404
Domain	SH3_9	ABI2 ARHGAP10 SNX18 RIMBP2 SORBS1 ARHGAP33	5.04e-07	78	71	6	PF14604
Domain	Period_circadian-like_C	PER2 PER1	4.26e-05	3	71	2	IPR022728
Domain	Period_C	PER2 PER1	4.26e-05	3	71	2	PF12114
Domain	C1	KMT2C TNS2 AKAP13 GMIP	1.09e-04	65	71	4	SM00109
Domain	PE/DAG-bd	KMT2C TNS2 AKAP13 GMIP	1.16e-04	66	71	4	IPR002219
Domain	FYrich_C	KMT2C KMT2D	1.41e-04	5	71	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	1.41e-04	5	71	2	IPR003888
Domain	FYRC	KMT2C KMT2D	1.41e-04	5	71	2	SM00542
Domain	FYRN	KMT2C KMT2D	1.41e-04	5	71	2	SM00541
Domain	FYRN	KMT2C KMT2D	1.41e-04	5	71	2	PF05964
Domain	FYRC	KMT2C KMT2D	1.41e-04	5	71	2	PF05965
Domain	FYRC	KMT2C KMT2D	1.41e-04	5	71	2	PS51543
Domain	FYRN	KMT2C KMT2D	1.41e-04	5	71	2	PS51542
Domain	SH3	ABI2 ARHGAP10 SNX18 RIMBP2 SORBS1 ARHGAP33	1.71e-04	216	71	6	SM00326
Domain	SH3	ABI2 ARHGAP10 SNX18 RIMBP2 SORBS1 ARHGAP33	1.71e-04	216	71	6	PS50002
Domain	SH3_domain	ABI2 ARHGAP10 SNX18 RIMBP2 SORBS1 ARHGAP33	1.89e-04	220	71	6	IPR001452
Domain	SH3_2	SNX18 RIMBP2 SORBS1 ARHGAP33	3.22e-04	86	71	4	IPR011511
Domain	SH3_2	SNX18 RIMBP2 SORBS1 ARHGAP33	3.22e-04	86	71	4	PF07653
Domain	SH3_1	ABI2 ARHGAP10 SNX18 SORBS1 ARHGAP33	4.01e-04	164	71	5	PF00018
Domain	-	GATA3 NR4A1 NR1D1	1.33e-03	57	71	3	3.30.50.10
Domain	Znf_NHR/GATA	GATA3 NR4A1 NR1D1	1.40e-03	58	71	3	IPR013088
Domain	Post-SET_dom	KMT2C KMT2D	1.65e-03	16	71	2	IPR003616
Domain	PostSET	KMT2C KMT2D	1.65e-03	16	71	2	SM00508
Domain	POST_SET	KMT2C KMT2D	1.65e-03	16	71	2	PS50868
Domain	RhoGAP	ARHGAP10 GMIP ARHGAP33	1.70e-03	62	71	3	SM00324
Domain	RhoGAP	ARHGAP10 GMIP ARHGAP33	1.78e-03	63	71	3	PF00620
Domain	ZF_DAG_PE_1	TNS2 AKAP13 GMIP	1.86e-03	64	71	3	PS00479
Domain	ZF_DAG_PE_2	TNS2 AKAP13 GMIP	1.86e-03	64	71	3	PS50081
Domain	RHOGAP	ARHGAP10 GMIP ARHGAP33	1.86e-03	64	71	3	PS50238
Domain	RhoGAP_dom	ARHGAP10 GMIP ARHGAP33	1.86e-03	64	71	3	IPR000198
Domain	-	ARHGAP10 GMIP ARHGAP33	1.86e-03	64	71	3	1.10.555.10
Domain	EPHD	KMT2C KMT2D	3.13e-03	22	71	2	PS51805
Domain	PAS_fold_3	PER2 PER1	3.42e-03	23	71	2	IPR013655
Domain	PAS_3	PER2 PER1	3.42e-03	23	71	2	PF08447
Domain	-	ARHGAP10 ENAH DNM3 TNS2 AKAP13 SOS1	3.69e-03	391	71	6	2.30.29.30
Domain	PAS-assoc_C	PER2 PER1	3.73e-03	24	71	2	IPR000700
Domain	PAC	PER2 PER1	4.37e-03	26	71	2	IPR001610
Domain	-	SCAF8 GGA3	4.37e-03	26	71	2	1.25.40.90
Domain	PAC	PER2 PER1	4.37e-03	26	71	2	SM00086
Domain	PAC	PER2 PER1	4.37e-03	26	71	2	PS50113
Domain	Rho_GTPase_activation_prot	ARHGAP10 GMIP ARHGAP33	4.59e-03	88	71	3	IPR008936
Domain	ENTH_VHS	SCAF8 GGA3	5.41e-03	29	71	2	IPR008942
Domain	PH_dom-like	ARHGAP10 ENAH DNM3 TNS2 AKAP13 SOS1	5.59e-03	426	71	6	IPR011993
Domain	PAS	PER2 PER1	6.57e-03	32	71	2	SM00091
Domain	PAS	PER2 PER1	7.39e-03	34	71	2	IPR000014
Domain	PAS	PER2 PER1	7.39e-03	34	71	2	PS50112
Pathway	KEGG_CIRCADIAN_RHYTHM_MAMMAL	PER2 PER1 NR1D1	1.32e-05	13	52	3	M18009
Pathway	PID_CIRCADIAN_PATHWAY	PER2 PER1 NR1D1	2.56e-05	16	52	3	M95
Pathway	REACTOME_RAC1_GTPASE_CYCLE	ABI2 ARHGAP10 WASF3 GMIP ARHGAP33 SOS1	4.26e-05	175	52	6	MM15599
Pathway	REACTOME_RAC1_GTPASE_CYCLE	ABI2 ARHGAP10 WASF3 GMIP ARHGAP33 SOS1	5.64e-05	184	52	6	M41809
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2C JUND KMT2D AATK PER2 SZT2 TMEM94 BICRA BRD4 ZBTB4 FBRSL1 PER1 AKAP13 ZNF579 SYVN1 MBD6 ZNF865 TESK1 DENND1A WNK2 ARHGAP33 GGA3	6.85e-16	1105	74	22	35748872
Pubmed	Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder.	PER2 PER1 NR1D1	3.69e-08	4	74	3	30195196
Pubmed	Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance.	PER2 TIPIN PER1 NR1D1	5.65e-08	18	74	4	20174623
Pubmed	Klf15 orchestrates circadian nitrogen homeostasis.	PER2 PER1 NR1D1	9.22e-08	5	74	3	22405069
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	HOXB2 KMT2C KMT2D BICRA BRD4 BCORL1 FBRSL1 SIX5 RAI2	1.76e-07	398	74	9	35016035
Pubmed	The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.	PER2 PER1 NR1D1	1.84e-07	6	74	3	12150932
Pubmed	The trophoblast clock controls transport across placenta in mice.	PER2 PER1 NR1D1	3.22e-07	7	74	3	33913482
Pubmed	Differential expression of the circadian clock in maternal and embryonic tissues of mice.	PER2 PER1 NR1D1	3.22e-07	7	74	3	20352049
Pubmed	Machine learning helps identify CHRONO as a circadian clock component.	PER2 PER1 NR1D1	5.14e-07	8	74	3	24737000
Pubmed	The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors.	PER2 PER1 NR1D1	7.70e-07	9	74	3	20159955
Pubmed	Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.	PER2 PER1 NR1D1	2.01e-06	12	74	3	14645221
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PER2 TMEM94 SCAF8 DNM3 RIMBP2 SORBS1 SYVN1 GGA3	2.52e-06	407	74	8	12693553
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KMT2C JUND PER2 BRD4 GATA3 SIX5 NR4A1 ZNF467 NR1D1 THAP7	2.58e-06	709	74	10	22988430
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	AATK XIRP2 BICRA AKAP13 ZNF804A WNK2 GGA3 SOS1	3.78e-06	430	74	8	35044719
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KMT2C MLXIPL SF3B4 MOGS PELP1 SZT2 BICRA SF3A1 BRD4 WBP1L SYVN1 CAPN15 SOS1	4.11e-06	1327	74	13	32694731
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	4.47e-06	2	74	2	28483418
Pubmed	Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine.	PER2 PER1	4.47e-06	2	74	2	28710114
Pubmed	Refeeding after fasting elicits insulin-dependent regulation of Per2 and Rev-erbα with shifts in the liver clock.	PER2 NR1D1	4.47e-06	2	74	2	21628550
Pubmed	Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart.	PER2 PER1	4.47e-06	2	74	2	23977055
Pubmed	De novo synthesis of PERIOD initiates circadian oscillation in cultured mouse suprachiasmatic nucleus after prolonged inhibition of protein synthesis by cycloheximide.	PER2 PER1	4.47e-06	2	74	2	22236088
Pubmed	Expression of circadian Per1 and Per2 genes in the liver and breast tumor tissues of HER2/neu transgenic mice of different age.	PER2 PER1	4.47e-06	2	74	2	22238756
Pubmed	Masking responses to light in period mutant mice.	PER2 PER1	4.47e-06	2	74	2	21793695
Pubmed	Alterations in the expression of Per1 and Per2 induced by Aβ31-35 in the suprachiasmatic nucleus, hippocampus, and heart of C57BL/6 mouse.	PER2 PER1	4.47e-06	2	74	2	27021954
Pubmed	Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer.	PER2 PER1	4.47e-06	2	74	2	24551282
Pubmed	Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.	TICAM1 SOS1	4.47e-06	2	74	2	15767257
Pubmed	Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions.	ATXN7 SORBS1	4.47e-06	2	74	2	11371513
Pubmed	Constant darkness is a circadian metabolic signal in mammals.	PER2 PER1	4.47e-06	2	74	2	16421573
Pubmed	Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock.	PER2 PER1	4.47e-06	2	74	2	11389837
Pubmed	Circadian regulation of central ethanol sensitivity by the mPer2 gene.	PER2 PER1	4.47e-06	2	74	2	19523042
Pubmed	Cocaine sensitization and reward are under the influence of circadian genes and rhythm.	PER2 PER1	4.47e-06	2	74	2	12084940
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	4.47e-06	2	74	2	34156443
Pubmed	Differential daily expression of Per1 and Per2 mRNA in the suprachiasmatic nucleus of fetal and early postnatal mice.	PER2 PER1	4.47e-06	2	74	2	11207804
Pubmed	Resetting the brain clock: time course and localization of mPER1 and mPER2 protein expression in suprachiasmatic nuclei during phase shifts.	PER2 PER1	4.47e-06	2	74	2	15009158
Pubmed	Insights into structure and activity relationship of clinically mutated PER1 and PER2 class A β-lactamase enzymes.	PER2 PER1	4.47e-06	2	74	2	35475497
Pubmed	Time-dependent inhibitory effect of lipopolysaccharide injection on Per1 and Per2 gene expression in the mouse heart and liver.	PER2 PER1	4.47e-06	2	74	2	20370466
Pubmed	cAMP-dependent signaling as a core component of the mammalian circadian pacemaker.	PER2 PER1	4.47e-06	2	74	2	18487196
Pubmed	Decoupling PER phosphorylation, stability and rhythmic expression from circadian clock function by abolishing PER-CK1 interaction.	PER2 PER1	4.47e-06	2	74	2	35810166
Pubmed	Cardiac atrial circadian rhythms in PERIOD2::LUCIFERASE and per1:luc mice: amplitude and phase responses to glucocorticoid signaling and medium treatment.	PER2 PER1	4.47e-06	2	74	2	23110090
Pubmed	Circadian Modulation of Neurons and Astrocytes Controls Synaptic Plasticity in Hippocampal Area CA1.	PER2 PER1	4.47e-06	2	74	2	33053337
Pubmed	Presence of multiple peripheral circadian oscillators in the tissues controlling voiding function in mice.	PER2 PER1	4.47e-06	2	74	2	24603368
Pubmed	The circadian clock protects against ionizing radiation-induced cardiotoxicity.	PER2 PER1	4.47e-06	2	74	2	31919902
Pubmed	Period gene expression in mouse endocrine tissues.	PER2 PER1	4.47e-06	2	74	2	12775559
Pubmed	Circadian time-dependent tumor suppressor function of period genes.	PER2 PER1	4.47e-06	2	74	2	19926612
Pubmed	Per2 is a C/EBP target gene implicated in myeloid leukemia.	PER2 NR1D1	4.47e-06	2	74	2	19926610
Pubmed	Forebrain oscillators ticking with different clock hands.	PER2 PER1	4.47e-06	2	74	2	17996461
Pubmed	Circadian gene expression is resilient to large fluctuations in overall transcription rates.	PER2 PER1	4.47e-06	2	74	2	19078963
Pubmed	The circadian clock and tumor suppression by mammalian period genes.	PER2 PER1	4.47e-06	2	74	2	15817328
Pubmed	Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing?	PER2 PER1	4.47e-06	2	74	2	18367514
Pubmed	Temporal expression profiles of ceramide and ceramide-related genes in wild-type and mPer1/mPer2 double knockout mice.	PER2 PER1	4.47e-06	2	74	2	21773940
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	4.47e-06	2	74	2	31924266
Pubmed	Homeostatic sleep regulation is preserved in mPer1 and mPer2 mutant mice.	PER2 PER1	4.47e-06	2	74	2	12383239
Pubmed	Segregation of expression of mPeriod gene homologs in neurons and glia: possible divergent roles of mPeriod1 and mPeriod2 in the brain.	PER2 PER1	4.47e-06	2	74	2	19477955
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	4.47e-06	2	74	2	27280393
Pubmed	Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects.	PER2 PER1	4.47e-06	2	74	2	23351077
Pubmed	Circadian clock genes Per1 and Per2 regulate the response of metabolism-associated transcripts to sleep disruption.	PER2 PER1	4.47e-06	2	74	2	23285241
Pubmed	Core circadian clock genes Per1 and Per2 regulate the rhythm in photoreceptor outer segment phagocytosis.	PER2 PER1	4.47e-06	2	74	2	34160105
Pubmed	Iron accumulation with age alters metabolic pattern and circadian clock gene expression through the reduction of AMP-modulated histone methylation.	PER2 PER1	4.47e-06	2	74	2	35460695
Pubmed	Robust circadian rhythmicity of Per1 and Per2 mutant mice in constant light, and dynamics of Per1 and Per2 gene expression under long and short photoperiods.	PER2 PER1	4.47e-06	2	74	2	12054191
Pubmed	Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms.	PER2 PER1	4.47e-06	2	74	2	9920673
Pubmed	Endogenous circadian reporters reveal functional differences of PERIOD paralogs and the significance of PERIOD:CK1 stable interaction.	PER2 PER1	4.47e-06	2	74	2	36724252
Pubmed	mPer1 and mPer2 mutant mice show regular spatial and contextual learning in standardized tests for hippocampus-dependent learning.	PER2 PER1	4.47e-06	2	74	2	15959842
Pubmed	Histone methyltransferase MLL4 protects against pressure overload-induced heart failure via a THBS4-mediated protection in ER stress.	THBS4 KMT2D	4.47e-06	2	74	2	38876442
Pubmed	Influence of photoperiod duration and light-dark transitions on entrainment of Per1 and Per2 gene and protein expression in subdivisions of the mouse suprachiasmatic nucleus.	PER2 PER1	4.47e-06	2	74	2	19840112
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	4.47e-06	2	74	2	36869380
Pubmed	Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiency†.	PER2 PER1	4.47e-06	2	74	2	30452546
Pubmed	Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.	SF3B4 ENAH	4.47e-06	2	74	2	35030977
Pubmed	Differential effects of two period genes on the physiology and proteomic profiles of mouse anterior tibialis muscles.	PER2 PER1	4.47e-06	2	74	2	17202855
Pubmed	Light-induced phase shifts in mice lacking mPER1 or mPER2.	PER2 PER1	4.47e-06	2	74	2	12693867
Pubmed	Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.	PER2 PER1	4.47e-06	2	74	2	23039899
Pubmed	Cones are required for normal temporal responses to light of phase shifts and clock gene expression.	PER2 PER1	4.47e-06	2	74	2	20560710
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	4.47e-06	2	74	2	28967912
Pubmed	Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice.	PER2 PER1	4.47e-06	2	74	2	21624349
Pubmed	Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality.	PER2 PER1	4.47e-06	2	74	2	31260634
Pubmed	Phase shifts and Per gene expression in mouse suprachiasmatic nucleus.	PER2 PER1	4.47e-06	2	74	2	12824769
Pubmed	Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse.	PER2 PER1	4.47e-06	2	74	2	12372028
Pubmed	Circadian rhythms of hedonic drinking behavior in mice.	PER2 PER1	4.47e-06	2	74	2	28286126
Pubmed	Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins.	PER2 PER1	4.47e-06	2	74	2	26862173
Pubmed	Age and oestrus cycle-related changes in glucocorticoid excretion and wheel-running activity in female mice carrying mutations in the circadian clock genes Per1 and Per2.	PER2 PER1	4.47e-06	2	74	2	18786554
Pubmed	Physiological and Molecular Dissection of Daily Variance in Exercise Capacity.	PER2 PER1	4.47e-06	2	74	2	31006590
Pubmed	Per1/Per2 knockout Affects Spleen Immune Function in Elderly Mice via Inducing Spleen Lymphocyte Ferroptosis.	PER2 PER1	4.47e-06	2	74	2	36361751
Pubmed	Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis.	PER2 PER1	4.47e-06	2	74	2	24091726
Pubmed	A suprachiasmatic-independent circadian clock(s) in the habenula is affected by Per gene mutations and housing light conditions in mice.	PER2 PER1	4.47e-06	2	74	2	30242505
Pubmed	Deregulated expression of the Per1 and Per2 in human gliomas.	PER2 PER1	4.47e-06	2	74	2	20481271
Pubmed	Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.	PER2 PER1	4.47e-06	2	74	2	17971899
Pubmed	Stromal Expression of the Core Clock Gene Period 2 Is Essential for Tumor Initiation and Metastatic Colonization.	PER2 PER1	4.47e-06	2	74	2	33123539
Pubmed	Time-place learning and memory persist in mice lacking functional Per1 and Per2 clock genes.	PER2 PER1	4.47e-06	2	74	2	24336415
Pubmed	Distinct phase relationships between suprachiasmatic molecular rhythms, cerebral cortex molecular rhythms, and behavioral rhythms in early runner (CAST/EiJ) and nocturnal (C57BL/6J) mice.	PER2 PER1	4.47e-06	2	74	2	23024437
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	4.47e-06	2	74	2	25346535
Pubmed	The circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels.	PER2 PER1	4.47e-06	2	74	2	23608482
Pubmed	Circadian rhythms in Per1, PER2 and Ca2+ of a solitary SCN neuron cultured on a microisland.	PER2 PER1	4.47e-06	2	74	2	31797953
Pubmed	Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland.	PER2 PER1	4.47e-06	2	74	2	17715397
Pubmed	Host circadian behaviors exert only weak selective pressure on the gut microbiome under stable conditions but are critical for recovery from antibiotic treatment.	PER2 PER1	4.47e-06	2	74	2	36350921
Pubmed	Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistance.	PER2 PER1	4.47e-06	2	74	2	24770415
Pubmed	Rigid Cooperation of Per1 and Per2 proteins.	PER2 PER1	4.47e-06	2	74	2	27609640
Pubmed	Lack of food anticipation in Per2 mutant mice.	PER2 PER1	4.47e-06	2	74	2	17055980
Pubmed	Daily variation in global and local DNA methylation in mouse livers.	PER2 PER1	4.47e-06	2	74	2	25689298
Pubmed	Per1/Per2 Disruption Reduces Testosterone Synthesis and Impairs Fertility in Elderly Male Mice.	PER2 PER1	4.47e-06	2	74	2	35806403
Pubmed	Restraint of IFN-γ expression through a distal silencer CNS-28 for tissue homeostasis.	KMT2D GATA3	4.47e-06	2	74	2	37040761
Pubmed	Chronic circadian disturbance by a shortened light-dark cycle increases mortality.	PER2 PER1	4.47e-06	2	74	2	22154820
Pubmed	Structural basis for recognition of the third SH3 domain of full-length R85 (R85FL)/ponsin by ataxin-7.	ATXN7 SORBS1	4.47e-06	2	74	2	23892081
Interaction	TOP3B interactions	KMT2C JUND KMT2D AATK PER2 MOGS PELP1 SZT2 TMEM94 BICRA BRD4 ZBTB4 FBRSL1 PER1 AKAP13 ZNF579 SYVN1 MBD6 ZNF865 TESK1 DENND1A WNK2 ARHGAP33 GGA3	1.12e-10	1470	72	24	int:TOP3B
Interaction	CRX interactions	KMT2C KMT2D SZT2 ABI2 ATXN7 BICRA BCORL1 FBRSL1 TNS2	2.97e-07	254	72	9	int:CRX
Interaction	TLE3 interactions	JUND KMT2D SCAF8 BRD4 BCORL1 ZBTB4 GATA3 FBRSL1 RNF216	7.52e-06	376	72	9	int:TLE3
Interaction	EYA4 interactions	SF3B4 AATK PELP1 BICRA FBRSL1 SIX5 NR4A1	2.57e-05	243	72	7	int:EYA4
Cytoband	Ensembl 112 genes in cytogenetic band chr17q25	AATK RBFOX3 TMEM94 JPT1 GGA3	1.43e-04	307	74	5	chr17q25
Cytoband	17q25.1	TMEM94 JPT1 GGA3	3.13e-04	81	74	3	17q25.1
Cytoband	9q33.3	GARNL3 DENND1A	1.65e-03	37	74	2	9q33.3
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	SPEM3 PELP1 ZBTB4 PER1	2.41e-03	346	74	4	chr17p13
Cytoband	12q24.33	FBRSL1 RIMBP2	2.76e-03	48	74	2	12q24.33
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	BICRA SIX5 IRGQ ZNF579 ZNF865 ARHGAP33 ADM5	3.10e-03	1192	74	7	chr19q13
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP10 GMIP ARHGAP33	3.35e-04	50	49	3	721
Coexpression	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	JUND KMT2D ARHGAP10 SF3A1 BRD4 SNX18 PER1 DNM3 NR4A1	4.11e-09	200	72	9	M7764
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	HOXB2 SF3B4 MOGS BICRA TICAM1 MMP23B RNF216 AKAP13 GMIP SYVN1 MBD6 ZNF467 ADAM8 ARHGAP33 GGA3	1.94e-08	905	72	15	M40865
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	KMT2D GARNL3 GATA3 FBRSL1 IRGQ ZNF467 TESK1 DENND1A GGA3	1.09e-06	385	72	9	M2840
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	JUND SF3B4 MOGS BICRA RNF216 AKAP13 MBD6 ADAM8 ARHGAP33 GGA3	8.89e-06	634	72	10	M40866
Coexpression	GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP	PER2 SNX18 GATA3 PER1 NR4A1 PALLD	1.83e-05	199	72	6	M7885
Coexpression	GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN	MOGS MMP23B SMR3A TNS2 MBD6 THAP7	1.88e-05	200	72	6	M3680
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	AATK RBFOX3 GARNL3 NRXN2 GATA3 DNM3 RIMBP2 SEZ6	3.25e-05	450	72	8	M39072
Coexpression	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	ENAH GATA3 DNM3 AKAP13 JPT1 SORBS1 NR4A1 RAI2	3.85e-05	461	72	8	M14127
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	KMT2D MOGS SZT2 BICRA TICAM1 FBRSL1 CAPN15	4.00e-05	338	72	7	M17094
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	HOXB2 KMT2C JUND KMT2D ATXN7 SCAF8 SF3A1 ZBTB4 GATA3 RNF216 AKAP13 GMIP ADAM8 SOS1	4.69e-05	1492	72	14	M40023
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MACROPHAGE_AGEING	JUND SF3B4 GATA3 NR4A1	6.09e-05	77	72	4	MM3781
Coexpression	VERHAAK_GLIOBLASTOMA_PRONEURAL	NRXN2 DNM3 JPT1 ZNF804A ARHGAP33	1.29e-04	177	72	5	M2115
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KMT2C PELP1 TMEM94 SF3A1 SOS1	1.39e-04	180	72	5	M8239
Coexpression	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN	ABI2 PER1 TNS2 NR4A1 DENND1A	1.84e-04	191	72	5	M8802
Coexpression	GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	JUND BCORL1 ZBTB4 SIX5 MBD6	2.17e-04	198	72	5	M7480
Coexpression	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	KMT2C ATXN7 SNX18 AKAP13 SYVN1	2.22e-04	199	72	5	M3517
Coexpression	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	SF3B4 PER1 MBD6 ZNF467 ADAM8	2.22e-04	199	72	5	M7906
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	KMT2C ATXN7 ZBTB4 NR1D1 GGA3	2.22e-04	199	72	5	M3583
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	MOGS SZT2 BRD4 RNF216 TESK1	2.22e-04	199	72	5	M7254
Coexpression	GSE3982_BCELL_VS_TH2_DN	HOXB2 GATA3 JPT1 PALLD RAI2	2.22e-04	199	72	5	M5555
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	KMT2C KMT2D SZT2 ZBTB4 GGA3	2.27e-04	200	72	5	M9439
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	KMT2D SZT2 ATXN7 AKAP13 TESK1	2.27e-04	200	72	5	M9463
Coexpression	GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	NRXN2 SNX18 GATA3 PER1 NR4A1	2.27e-04	200	72	5	M7881
Coexpression	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	KMT2D PELP1 ZBTB4 NR4A1 CAPN15	2.27e-04	200	72	5	M6585
Coexpression	GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN	PER2 BICRA PER1 DENND1A WNK2	2.27e-04	200	72	5	M7822
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RBFOX3 GARNL3 ARHGAP10 ENAH SORBS1 ZNF804A PALLD	2.76e-08	190	73	7	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RBFOX3 GARNL3 ARHGAP10 ENAH SORBS1 ZNF804A PALLD	2.76e-08	190	73	7	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RBFOX3 ARHGAP10 ENAH SORBS1 ZNF804A PALLD WNK2	3.42e-08	196	73	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RBFOX3 ARHGAP10 ENAH SORBS1 ZNF804A PALLD WNK2	3.42e-08	196	73	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	(00)_Basal-(4)_1wkpi\|(00)_Basal / shred by cell type and Timepoint	JUND PER2 PER1 TNS2 NR4A1 NR1D1	6.03e-07	185	73	6	bf82ba905e5eee1c39a2731702071d3de10a78b8
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KMT2C SZT2 AKAP13 TYMP ADAM8 DENND1A	9.24e-07	199	73	6	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	AATK PER1 NR4A1 NR1D1 ARHGAP33	6.80e-06	161	73	5	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MLXIPL JUND PER1 NR4A1 TYMP	8.61e-06	169	73	5	0867528101767fc65e93b3561480bf830c50368d
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN2 ARHGAP10 ZNF467 TYMP ADAM8	1.02e-05	175	73	5	393da565f61ba640410419a0cabaaf5c1056580a
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN2 ARHGAP10 ZNF467 TYMP ADAM8	1.02e-05	175	73	5	271b56d4ab940959d28ca4b86ce2750350dfc717
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN2 ARHGAP10 ZNF467 TYMP ADAM8	1.02e-05	175	73	5	5168340c6045bbc7d67276afb719b051d1cb65a2
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	XIRP2 ENAH RNF216 SORBS1 PALLD	1.23e-05	182	73	5	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	AATK WASF3 MMP23B RIMBP2 RAI2	1.27e-05	183	73	5	6821dca076318115d360ff426eb1218cfe104063
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	XIRP2 AKAP13 SORBS1 PALLD WNK2	1.48e-05	189	73	5	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 PER1 AKAP13 RIMBP2 NR4A1	1.48e-05	189	73	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	XIRP2 ENAH AKAP13 SORBS1 PALLD	1.48e-05	189	73	5	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	XIRP2 ENAH AKAP13 SORBS1 PALLD	1.52e-05	190	73	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	XIRP2 AKAP13 SORBS1 PALLD WNK2	1.72e-05	195	73	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND SORBS1 NR4A1 PALLD RAI2	1.72e-05	195	73	5	f41a68b7c2621594db8d8952e301eeadc96be26f
ToppCell	wk_08-11-Hematologic-Myeloid-Myelocyte-like\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	TIPIN ZBTB4 ZNF467 TYMP RAI2	1.76e-05	196	73	5	4b88c96b737a747422674ad99c073b28e6febc7c
ToppCell	P07-Mesenchymal-myocytic_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HOXB2 MMP23B NR4A1 PALLD RAI2	1.80e-05	197	73	5	378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	NRXN2 ARHGAP10 SNX18 FBRSL1 RIMBP2	1.80e-05	197	73	5	e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GARNL3 ARHGAP10 ENAH SORBS1 PALLD	1.80e-05	197	73	5	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	XIRP2 GMIP ADAM8 ZNF804A ARHGAP33	1.89e-05	199	73	5	6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-3\|TCGA-Uvea / Sample_Type by Project: Shred V9	JUND ZNF579 ZNF865 TESK1	1.14e-04	152	73	4	009061d387115d9c3f76d0530cf7d707d2b8cbf4
ToppCell	normal_Lung-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	THBS4 ENAH ZNF467 TYMP	1.20e-04	154	73	4	835ef49d314ecbcbfd8d1041ba202a5eedcda0bd
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	THBS4 PCDH15 TNS2 RIMBP2	1.23e-04	155	73	4	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AATK PER1 NR4A1 PALLD	1.42e-04	161	73	4	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	MLXIPL SZT2 AKAP13 SORBS1	1.45e-04	162	73	4	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	1.45e-04	162	73	4	5f009b231f21861afee9cc0c569082e1135f929c
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AATK PER1 NR4A1 PALLD	1.45e-04	162	73	4	0fa93efc9c005d1e649b3f7069ae8641d6e41ed8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	1.45e-04	162	73	4	b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	XIRP2 SORBS1 PALLD WNK2	1.75e-04	170	73	4	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	THBS4 GARNL3 RIMBP2 SORBS1	1.75e-04	170	73	4	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBFOX3 GARNL3 SORBS1 PALLD	1.87e-04	173	73	4	f8e3dded726bb3a6c24bfedf8c6732bb46262308
ToppCell	facs-Skin-nan-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND WASF3 PALLD RAI2	1.95e-04	175	73	4	f1166b567bca80dac3abe90c3dc544c831006640
ToppCell	(03)_Secretory-(4)_1wkpi\|(03)_Secretory / shred by cell type and Timepoint	JUND PER2 PER1 NR4A1	1.95e-04	175	73	4	06b52f85baa31b55bb31477244892b6da79fe2c9
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI2 ATXN7 FBRSL1 ADAM8	2.00e-04	176	73	4	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JUND PER1 AKAP13 NR4A1	2.00e-04	176	73	4	a31d7532f8c055d4e62bbaa78d819f2495bfee00
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PCDH15 SORBS1 ZNF804A SEZ6	2.00e-04	176	73	4	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	systemic_lupus_erythematosus-managed\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	JUND TIPIN PER1 NR4A1	2.00e-04	176	73	4	e406a05345461d23cba21c5444223c937143e96a
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NR4A1 ZNF467 ADAM8 PALLD	2.04e-04	177	73	4	c9e5820ff0bc7ad1adcfb2651713fdfc58bced56
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP10 TYMP ADAM8 PALLD	2.04e-04	177	73	4	d34b086a5931d7f1737a504952d51c47693e91a8
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS4 RBFOX3 MMP23B NR1D1	2.08e-04	178	73	4	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THBS4 RBFOX3 MMP23B NR1D1	2.08e-04	178	73	4	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC\|lymph-node_spleen / Manually curated celltypes from each tissue	RBFOX3 NRXN2 ARHGAP10 PALLD	2.22e-04	181	73	4	94680f8dbdf22d83801abc0819417751d363fb12
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	XIRP2 AKAP13 SORBS1 PALLD	2.36e-04	184	73	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AATK XIRP2 WASF3 DNM3	2.41e-04	185	73	4	9bff336510c80cd762b4e41b4570475033e709ca
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	XIRP2 SORBS1 PALLD WNK2	2.41e-04	185	73	4	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AATK XIRP2 WASF3 DNM3	2.41e-04	185	73	4	452d49c7835a4d55e41caefa44dac5cab30e7ced
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AATK XIRP2 WASF3 DNM3	2.41e-04	185	73	4	53f5136ee1bd101dd5ac8a2c9e63b0c3b987657e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AATK XIRP2 WASF3 DNM3	2.41e-04	185	73	4	67ac5c2bacdbdcb40ee65c44da55b3f597b410ee
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND PER1 NR4A1 TESK1	2.46e-04	186	73	4	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBFOX3 SORBS1 PALLD RAI2	2.51e-04	187	73	4	e1b41560c26795a7d353b9468b1bb6fc7c6b379e
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	GARNL3 ARHGAP10 ENAH SORBS1	2.57e-04	188	73	4	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	THBS4 NRXN2 MMP23B SIX5	2.57e-04	188	73	4	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THBS4 NRXN2 SNX18 NR4A1	2.62e-04	189	73	4	f7d57723b8fb0f1e1485f51e3eff93ec0f39761e
ToppCell	control-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IRGQ NR4A1 ZNF467 GGA3	2.62e-04	189	73	4	bdfd120900ba58d5e54765f7b576e1f8cc2401bf
ToppCell	facs-Skin-nan-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND GATA3 NR4A1 WNK2	2.62e-04	189	73	4	6c71e81373cb7822de23c193a6350b6df9f567bc
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND PER1 TESK1 PALLD	2.62e-04	189	73	4	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND GATA3 NR4A1 ADAM8	2.62e-04	189	73	4	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	AKAP13 SORBS1 PALLD WNK2	2.67e-04	190	73	4	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	AKAP13 SORBS1 PALLD WNK2	2.67e-04	190	73	4	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	AKAP13 SORBS1 PALLD WNK2	2.72e-04	191	73	4	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 WASF3 TNS2 PALLD	2.72e-04	191	73	4	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	JUND PER2 SORBS1 NR4A1	2.78e-04	192	73	4	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND NR4A1 PALLD RAI2	2.78e-04	192	73	4	c47df468cf78a90929913c9022e8078a53cdf680
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENAH SORBS1 NR4A1 PALLD	2.83e-04	193	73	4	4aa976b596830b585e8d9c808d5072ed23d13a7c
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	XIRP2 RNF216 SORBS1 PALLD	2.83e-04	193	73	4	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	2.83e-04	193	73	4	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JUND PER2 PER1 NR4A1	2.83e-04	193	73	4	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	2.83e-04	193	73	4	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENAH SORBS1 NR4A1 PALLD	2.83e-04	193	73	4	5578f7cb3ec68c9a38cc5304b618b81283024d5e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	2.83e-04	193	73	4	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HOXB2 TIPIN MMP23B PALLD	2.83e-04	193	73	4	f25bdd10ef531b8d8441ea84573078b4b1b0f105
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MLXIPL TMEM94 SYVN1 GGA3	2.89e-04	194	73	4	4c40d6b50675eae52c419d69e719a9223df02ae3
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MLXIPL TMEM94 SYVN1 GGA3	2.89e-04	194	73	4	99a90de637e3babec2131cdd9f05ea965d8a8f30
ToppCell	facs-Heart-RA-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUND NRXN2 MMP23B SNX18	2.89e-04	194	73	4	bc945450b350f597c3ff910d3a14a533d90086a8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 ENAH SORBS1 PALLD	2.89e-04	194	73	4	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JUND AKAP13 NR4A1 TYMP	2.89e-04	194	73	4	449ce4167d64c170d914e0250f739eabedcf915d
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUND GMIP TYMP ADAM8	2.95e-04	195	73	4	ae98215b7b7f22f1aca690920ce6092dc4a3c7db
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 ENAH SORBS1 PALLD	2.95e-04	195	73	4	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	JUND GATA3 PER1 NR1D1	2.95e-04	195	73	4	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUND GMIP TYMP ADAM8	2.95e-04	195	73	4	6fcab7aa4db958ccad0300adea9aaae52ace5bff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 ENAH SORBS1 PALLD	2.95e-04	195	73	4	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXB2 THBS4 DNM3 JPT1	2.95e-04	195	73	4	b25c534fc6320d4da6437ef1b27e32a5d5256f3e
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	KMT2C AKAP13 TYMP ADAM8	2.95e-04	195	73	4	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / disease group, cell group and cell class	PER1 NR4A1 ZNF467 ADAM8	2.95e-04	195	73	4	6419090b19de7b5d5140eaecf231860273da2c0d
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|World / Lineage, cell class and subclass	GATA3 PER1 AKAP13 NR1D1	3.01e-04	196	73	4	78b006922307c154622d71fcbc79ae5eed3f4b23
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 ENAH SORBS1 PALLD	3.01e-04	196	73	4	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	15-Distal-Mesenchymal\|Distal / Age, Tissue, Lineage and Cell class	HOXB2 ENAH MMP23B PALLD	3.01e-04	196	73	4	b8d95b5f4780e73d16dcc528e70a5496f0314373
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP10 SORBS1 NR4A1 PALLD	3.01e-04	196	73	4	ac4c8571bd792538f8df7b9bdd90ef58405fd3b1
ToppCell	control-immature_Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PER1 IRGQ ZNF467 GGA3	3.01e-04	196	73	4	e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	SNX18 JPT1 NR4A1 TYMP	3.01e-04	196	73	4	7fe97109a5a06b35fc081a85f341ea78da131323
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JUND ENAH SORBS1 PALLD	3.01e-04	196	73	4	45d1c0a962c4221c17393ee5566961d1deebf442
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP10 SORBS1 NR4A1 PALLD	3.01e-04	196	73	4	70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922
ToppCell	(000)_CD14+_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	PER1 NR4A1 ZNF467 TYMP	3.06e-04	197	73	4	cff498bc7b153f28dd013eaeb73ead4fb62fb44c
ToppCell	facs-Brain_Non-Myeloid\|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNM3 SORBS1 NR4A1 NR1D1	3.06e-04	197	73	4	a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 SORBS1 NR4A1 PALLD	3.06e-04	197	73	4	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 ENAH SORBS1 PALLD	3.06e-04	197	73	4	85a8f1d18e0dd1d31341f5131eecd217553bf042
Drug	Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A	THBS4 AATK MOGS SF3A1 AKAP13 IRGQ GMIP NR4A1 ADAM8	6.20e-09	180	73	9	1752_UP
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	HOXB2 AATK TICAM1 BCORL1 PER1 AKAP13 NR1D1	2.86e-06	193	73	7	2078_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	PER2 ATXN7 PER1 DNM3 ZNF467 NR1D1 ARHGAP33	3.17e-06	196	73	7	3796_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	ARHGAP10 TICAM1 SMR3A TNS2 RNF216 ZNF804A ARHGAP33	3.28e-06	197	73	7	6143_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A	THBS4 MOGS TMEM94 AKAP13 ZNF467 DENND1A CAPN15	3.39e-06	198	73	7	1595_DN
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SZT2 ATXN7 TMEM94 BCORL1 PER1 AKAP13 CAPN15	3.39e-06	198	73	7	7334_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; HL60; HG-U133A	ATXN7 BICRA PER1 AKAP13 NR4A1 TESK1	1.06e-05	155	73	6	1786_UP
Drug	CT 0	PER2 PER1 NR1D1	1.40e-05	15	73	3	CID002255489
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A	GATA3 DNM3 SMR3A TNS2 ADAM8 CAPN15	3.65e-05	193	73	6	6733_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A	TMEM94 BCORL1 RNF216 IRGQ DENND1A ARHGAP33	3.75e-05	194	73	6	1759_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A	WASF3 BCORL1 DNM3 NR1D1 ARHGAP33 CAPN15	3.86e-05	195	73	6	2151_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; PC3; HT_HG-U133A	SZT2 ARHGAP10 BRD4 PER1 ZNF467 ARHGAP33	3.97e-05	196	73	6	4473_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A	ABI2 TMEM94 BCORL1 PER1 NR4A1 TESK1	3.97e-05	196	73	6	2922_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	THBS4 TICAM1 PER1 ADAM8 ARHGAP33 GGA3	4.09e-05	197	73	6	2324_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	TICAM1 AKAP13 SORBS1 NR1D1 ADAM8 ARHGAP33	4.09e-05	197	73	6	2259_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	HOXB2 JUND TICAM1 GATA3 PER1 DNM3	4.09e-05	197	73	6	3708_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	SF3A1 TNS2 RNF216 AKAP13 ADAM8 SOS1	4.09e-05	197	73	6	2082_DN
Drug	estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A	SZT2 ARHGAP10 GATA3 AKAP13 RAI2 GGA3	4.21e-05	198	73	6	1241_UP
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A	SZT2 DNM3 NR4A1 ADAM8 RAI2 GGA3	4.21e-05	198	73	6	3356_UP
Drug	Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A	MOGS SZT2 PER1 RNF216 NR4A1 CAPN15	4.21e-05	198	73	6	4193_DN
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; PC3; HT_HG-U133A	JUND ARHGAP10 GATA3 SMR3A GMIP CAPN15	4.21e-05	198	73	6	4080_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PER2 TMEM94 TNS2 NR4A1 ADAM8 RAI2	4.21e-05	198	73	6	3882_DN
Drug	Griseofulvin [126-07-8]; Up 200; 11.2uM; HL60; HT_HG-U133A	ABI2 WASF3 BCORL1 AKAP13 RIMBP2 NR1D1	4.21e-05	198	73	6	2332_UP
Drug	Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A	AATK BCORL1 SMR3A SORBS1 NR4A1 TESK1	4.33e-05	199	73	6	3389_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	HOXB2 DNM3 DENND1A ARHGAP33 CAPN15 GGA3	4.33e-05	199	73	6	3616_DN
Drug	2-monochloropropanediol	GARNL3 TICAM1 GATA3 PER1 NR1D1	1.85e-04	164	73	5	ctd:C585004
Drug	Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT_HG-U133A	MLXIPL SZT2 PER1 NR4A1 TYMP	2.24e-04	171	73	5	2957_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	PER1 AKAP13 SORBS1 NR4A1 RAI2	2.37e-04	173	73	5	7105_UP
Drug	Parthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	JUND PER1 SORBS1 RAI2 SOS1	2.37e-04	173	73	5	5105_UP
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; HL60; HG-U133A	BICRA PER1 AKAP13 NR4A1 ADAM8	2.70e-04	178	73	5	1716_UP
Drug	Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; PC3; HT_HG-U133A	GATA3 PER1 NR1D1 ZNF804A RAI2	2.77e-04	179	73	5	6711_UP
Drug	brotizolam	PER2 PER1	2.80e-04	8	73	2	CID000002451
Drug	SCH 351591	PER1 NR1D1	2.80e-04	8	73	2	ctd:C459379
Drug	Mi-1	PER2 PER1	2.80e-04	8	73	2	CID000198746
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; HL60; HG-U133A	THBS4 AATK TMEM94 BCORL1 NR4A1	2.99e-04	182	73	5	1755_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TICAM1 PER1 DNM3 AKAP13 NR4A1	3.07e-04	183	73	5	1475_UP
Drug	Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	JUND PER1 IRGQ NR1D1 TESK1	3.07e-04	183	73	5	1343_UP
Drug	scriptaid; Up 200; 10uM; PC3; HT_HG-U133A	PER1 AKAP13 NR4A1 PALLD RAI2	3.14e-04	184	73	5	6919_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	HOXB2 PER2 BRD4 NR1D1 ARHGAP33	3.73e-04	191	73	5	3811_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	JUND ATXN7 SMR3A ZNF467 ADAM8	3.82e-04	192	73	5	4449_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	BICRA PER1 TNS2 NR4A1 ADAM8	3.82e-04	192	73	5	2271_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	THBS4 PER2 SF3A1 IRGQ GMIP	3.82e-04	192	73	5	1971_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	HOXB2 JUND SZT2 AKAP13 GGA3	3.91e-04	193	73	5	3773_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A	HOXB2 AATK ATXN7 BRD4 ADAM8	3.91e-04	193	73	5	4443_DN
Drug	oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA	JUND PER2 ABI2 BCORL1 PER1	3.91e-04	193	73	5	971_UP
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	SZT2 BRD4 PER1 SORBS1 GGA3	4.01e-04	194	73	5	6835_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	PER1 TNS2 NR1D1 ZNF804A ARHGAP33	4.01e-04	194	73	5	3861_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	THBS4 MOGS SMR3A ADAM8 TESK1	4.01e-04	194	73	5	3114_DN
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HOXB2 PER2 BCORL1 SMR3A SORBS1	4.10e-04	195	73	5	7326_UP
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; HL60; HT_HG-U133A	JUND ABI2 BICRA NR1D1 ARHGAP33	4.10e-04	195	73	5	2152_DN
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A	HOXB2 TICAM1 PER1 NR4A1 ARHGAP33	4.10e-04	195	73	5	2861_UP
Drug	Florfenicol [73231-34-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	JUND TICAM1 BCORL1 PER1 NR4A1	4.10e-04	195	73	5	3083_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	JUND SZT2 BRD4 GATA3 GGA3	4.10e-04	195	73	5	3732_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	AATK BRD4 GATA3 ZNF467 CAPN15	4.20e-04	196	73	5	6610_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	JUND BICRA AKAP13 CAPN15 SOS1	4.20e-04	196	73	5	6263_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	BRD4 PER1 AKAP13 NR1D1 CAPN15	4.20e-04	196	73	5	1323_UP
Drug	F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A	HOXB2 JUND ATXN7 SORBS1 NR4A1	4.20e-04	196	73	5	6401_UP
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; PC3; HT_HG-U133A	HOXB2 ATXN7 PER1 DNM3 SMR3A	4.20e-04	196	73	5	2112_UP
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	ABI2 WASF3 NR4A1 NR1D1 ADAM8	4.30e-04	197	73	5	2141_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; HL60; HT_HG-U133A	BCORL1 PER1 AKAP13 NR1D1 CAPN15	4.30e-04	197	73	5	1310_UP
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A	AATK DNM3 SMR3A RIMBP2 ADAM8	4.30e-04	197	73	5	3769_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; HL60; HG-U133A	THBS4 RNF216 GMIP CAPN15 THAP7	4.30e-04	197	73	5	1602_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; HL60; HT_HG-U133A	HOXB2 NR4A1 NR1D1 TESK1 CAPN15	4.30e-04	197	73	5	2463_UP
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	WASF3 GATA3 AKAP13 SORBS1 IRGQ	4.30e-04	197	73	5	2117_UP
Drug	Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A	MLXIPL AATK SZT2 NR1D1 SOS1	4.30e-04	197	73	5	3304_UP
Drug	U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A	HOXB2 BRD4 SORBS1 IRGQ ARHGAP33	4.30e-04	197	73	5	3818_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A	BICRA TICAM1 TNS2 AKAP13 NR4A1	4.30e-04	197	73	5	3211_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	SZT2 ATXN7 PER1 RNF216 SORBS1	4.30e-04	197	73	5	5734_UP
Drug	Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A	MOGS SZT2 ABI2 SMR3A TESK1	4.30e-04	197	73	5	2514_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	JUND BICRA TICAM1 RNF216 NR4A1	4.30e-04	197	73	5	7195_DN
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A	HOXB2 THBS4 AATK SMR3A NR4A1	4.30e-04	197	73	5	3512_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A	THBS4 SZT2 NR4A1 NR1D1 DENND1A	4.30e-04	197	73	5	1327_UP
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; HL60; HT_HG-U133A	ABI2 PER1 NR4A1 ADAM8 CAPN15	4.30e-04	197	73	5	2395_DN
Drug	Lisinopril [83915-83-7]; Down 200; 9uM; HL60; HT_HG-U133A	JUND ABI2 BCORL1 AKAP13 NR4A1	4.30e-04	197	73	5	2371_DN
Drug	Mecamylamine	KMT2C GATA3 SOS1	4.35e-04	46	73	3	ctd:D008464
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; HL60; HG-U133A	SZT2 ABI2 IRGQ NR1D1 DENND1A	4.40e-04	198	73	5	1428_DN
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A	HOXB2 JUND GATA3 NR4A1 NR1D1	4.40e-04	198	73	5	5805_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	JUND AATK ARHGAP10 PER1 CAPN15	4.40e-04	198	73	5	4551_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A	JUND GATA3 PER1 DNM3 GGA3	4.40e-04	198	73	5	5067_UP
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A	PER2 ARHGAP10 SORBS1 ARHGAP33 RAI2	4.40e-04	198	73	5	6557_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A	JUND SZT2 TICAM1 ARHGAP33 CAPN15	4.40e-04	198	73	5	2980_UP
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A	BCORL1 PER1 DNM3 TNS2 AKAP13	4.40e-04	198	73	5	2074_DN
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A	TMEM94 SF3A1 BRD4 AKAP13 ZNF467	4.40e-04	198	73	5	3261_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	BICRA SF3A1 BCORL1 RNF216 SOS1	4.40e-04	198	73	5	7174_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	SMR3A TNS2 GMIP CAPN15 SOS1	4.40e-04	198	73	5	4546_DN
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; PC3; HT_HG-U133A	JUND ATXN7 ZNF467 ADAM8 TESK1	4.40e-04	198	73	5	6730_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	SZT2 SMR3A GMIP NR1D1 CAPN15	4.40e-04	198	73	5	6622_DN
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	AATK ATXN7 SMR3A GMIP ARHGAP33	4.40e-04	198	73	5	6668_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	TICAM1 TNS2 ADAM8 ZNF804A THAP7	4.40e-04	198	73	5	4788_DN
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; PC3; HT_HG-U133A	BICRA BRD4 GATA3 DNM3 CAPN15	4.40e-04	198	73	5	4078_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	ABI2 BCORL1 PER1 IRGQ CAPN15	4.40e-04	198	73	5	2401_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MLXIPL BRD4 PER1 AKAP13 NR4A1	4.40e-04	198	73	5	4782_UP
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	AATK TICAM1 RIMBP2 RAI2 SOS1	4.40e-04	198	73	5	5491_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A	SZT2 AKAP13 IRGQ GMIP CAPN15	4.40e-04	198	73	5	7310_DN
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	JUND SZT2 GATA3 DNM3 NR4A1	4.50e-04	199	73	5	5048_UP
Drug	Rolitetracycline [751-97-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	PER1 DNM3 TNS2 ZNF467 ADAM8	4.50e-04	199	73	5	6731_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A	MOGS PER1 DNM3 CAPN15 GGA3	4.50e-04	199	73	5	3273_UP
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	SZT2 PER1 NR1D1 ADAM8 CAPN15	4.50e-04	199	73	5	2257_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	BRD4 TNS2 NR4A1 NR1D1 ARHGAP33	4.50e-04	199	73	5	3809_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	TICAM1 PER1 TNS2 NR1D1 ADAM8	4.50e-04	199	73	5	5824_DN
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	5.55e-06	2	70	2	DOID:0080598 (implicated_via_orthology)
Disease	Congenital small ears	KMT2D SF3B4 SIX5	1.28e-04	41	70	3	C0152423
Disease	corpus callosum posterior volume measurement	ZBTB4 ZNF804A SOS1	2.60e-04	52	70	3	EFO_0010298
Disease	pancreatic ductal carcinoma (is_marker_for)	TYMP ADAM8 PALLD	4.17e-04	61	70	3	DOID:3587 (is_marker_for)
Disease	congenital heart disease (implicated_via_orthology)	KMT2C KMT2D JPT1	5.99e-04	69	70	3	DOID:1682 (implicated_via_orthology)
Disease	testosterone measurement	MLXIPL SPEM3 ARHGAP10 WBP1L BCORL1 ZBTB4 DNM3 RIMBP2 GGA3 SOS1	8.21e-04	1275	70	10	EFO_0004908
Disease	Malignant neoplasm of breast	KMT2D PER2 TICAM1 BCORL1 GATA3 PER1 SORBS1 TESK1 GGA3	9.61e-04	1074	70	9	C0006142
Disease	Squamous cell carcinoma of esophagus	KMT2C KMT2D TYMP	1.51e-03	95	70	3	C0279626
Disease	Pancreatic Neoplasm	NR4A1 TYMP PALLD	1.75e-03	100	70	3	C0030297
Disease	neurotic disorder	AATK DNM3 ZNF804A	1.80e-03	101	70	3	EFO_0004257
Disease	Malignant neoplasm of pancreas	NR4A1 TYMP PALLD	1.86e-03	102	70	3	C0346647
Disease	Sezary Syndrome	KMT2C KMT2D	1.87e-03	27	70	2	C0036920
Disease	level of Sphingomyelin (d42:2) in blood serum	MLXIPL PELP1	2.16e-03	29	70	2	OBA_2045183
Disease	Myeloid Leukemia, Chronic	PER2 PER1	2.16e-03	29	70	2	C0023473
Disease	cervical cancer (is_marker_for)	SF3B4 SOS1	3.32e-03	36	70	2	DOID:4362 (is_marker_for)
Disease	lung non-small cell carcinoma (is_implicated_in)	KMT2C KMT2D TYMP	4.45e-03	139	70	3	DOID:3908 (is_implicated_in)
Disease	colorectal cancer, endometrial neoplasm	HOXB2 SCAF8	4.49e-03	42	70	2	EFO_0004230, MONDO_0005575

Protein segments in the cluster

Peptide	Gene	Start	Entry
SFFPSFPPAIPGLPT	FBRSL1	496	Q9HCM7
PLTPAPETVFPSPSP	ADM5	136	C9JUS6
AAPPEPATFPPFSGV	CXorf49;	346	A8MYA2
PPVQATPHPFPAVTP	BRD4	216	O60885
FAPTPVPAPTPAPIF	BCORL1	376	Q5H9F3
VPAPTPAPIFTPAPT	BCORL1	381	Q5H9F3
RIPSFFPSPEEPPSP	AKAP13	2696	Q12802
APPVTVSSPPFPVPV	ADAM8	751	P78325
IAVPTPSPPSVFPAP	ABI2	271	Q9NYB9
PVPPQPFSSPLSPLV	RAI2	211	Q9Y5P3
NTFRAAPPPPPIPTY	RBFOX3	236	A6NFN3
SGPPQPPAFFSFSPP	NR4A1	181	P22736
PPAFFSFSPPTGPSP	NR4A1	186	P22736
AAEPEPPRVPPFSPF	CAPN15	221	O75808
PFPFSPPATVADKPP	ARHGAP10	711	A1A4S6
APAPVPQPFSLPEPS	MBD6	391	Q96DN6
PPASPPIAFPPAFEA	KMT2C	4301	Q8NEZ4
APPPPPPAFSFQEFL	GMIP	356	Q9P107
ATVAFAAEPVPFPPP	JUND	211	P17535
VPFRPGPLPPFPSSS	DNM3	811	Q9UQ16
PPATTPFPAVVQPYP	PER1	871	O15534
QPLPPAPTSVPPAAF	PER1	896	O15534
APTSVPPAAFPAPLV	PER1	901	O15534
LPVFPAPGTVAAPPA	PER2	856	O15055
AAPVPSPVAPAPVPS	JPT1	126	Q9UK76
LPFPSPPVPLPFFLS	KRTAP4-16	166	G5E9R7
SSQAPLPPPFPAPVV	GGA3	456	Q9NZ52
VPPPEAPSPFRAPPF	PELP1	651	Q8IZL8
PPLAVPPTSVFSFFP	ATXN7	176	O15265
PALFPPVPLFTAVPS	MOGS	426	Q13724
TLIPPPPPFEQTFPS	HOXB2	41	P14652
PPPPPVFSPTAAFPV	PALLD	801	Q8WX93
AAFPVPDVFPLPPPP	PALLD	811	Q8WX93
ATRSPFVPPPPTFYP	NRXN2	391	P58401
PAPVPSPLVGFSQFP	NR1D1	256	P20393
APAPLAPPPDISPFS	PCDH15	1761	Q96QU1
PAPPAPASAFPPRVT	ARHGAP33	761	O14559
FTFPPTPPKDVSPDP	GATA3	151	P23771
FTPQFSFPPAGTPTP	DENND1A	811	Q8TEH3
GTPTPFPQPPLNPFV	DENND1A	821	Q8TEH3
PPPAPPLPASGFFLA	ENAH	366	Q8N8S7
PPPPPRTFQMVTTPF	BICRA	936	Q9NZM4
APAVPTVSLVPPAFP	SCAF8	646	Q9UPN6
SVPLFGPPLPTPPVF	GARNL3	351	Q5VVW2
SVPTAPTPFPAPERP	IRGQ	256	Q8WZA9
FPPVPPPPSSGEAVA	SYVN1	391	Q86TM6
STFPPAPVPGEPVTP	SZT2	2421	Q5T011
FVEFSTLPAGPPAPP	RIMBP2	476	O15034
APAPAAPTPTPAPFS	AATK	1321	Q6ZMQ8
EFPFPTVATTPPPPR	MMP23B	291	O75900
ATFPLPPGPVPAVAA	SIX5	436	Q8N196
PFPLPPVRPVFNNFP	RNF216	806	Q9NWF9
NAFFPNSPSPFTPPP	SOS1	1246	Q07889
AFVPAPPVAPVPAPA	SF3A1	651	Q15459
FSPRFPFPTVPPAPG	MLXIPL	431	Q9NP71
VSPLPAPAAFPPTPQ	MLXIPL	446	Q9NP71
APAAFPPTPQSVPSP	MLXIPL	451	Q9NP71
VPEFPCTFLPPTPAP	MLXIPL	561	Q9NP71
PFSPPPPADVTCFPV	THAP7	136	Q9BT49
AEFESFPGLPLPPPP	XIRP2	2161	A4UGR9
FQSPTPSTVVPPAPP	THBS4	266	P35443
PFTTPAPAPTGPFLP	ZNF414	241	Q96IQ9
LPPAFGAPPPPLFDA	ZNF865	126	P0CJ78
GAPPPPLFDAAFPTP	ZNF865	131	P0CJ78
PAPIITPIPSTPPAF	SPEM3	426	A0A1B0GUW6
LFPPFSPPPSPRGEV	TMEM94	216	Q12767
PFPQSPAFPTASPAP	TICAM1	656	Q8IUC6
FEPLPVAPPASFKPP	SNX18	86	Q96RF0
PPFFPVNSPTDPALP	SMR3A	116	Q99954
FAPISQTPPSFSPPP	SORBS1	231	Q9BX66
PPPPPVIPSAQTAFV	WASF3	346	Q9UPY6
PAPEPGPPPSVITFA	ZBTB4	461	Q9P1Z0
ALPFQPDPPAPFTPS	SEZ6	91	Q53EL9
PVLPLVPPSPFPSTQ	TESK1	401	Q15569
PTATVPPVPPPQYFS	WNK2	821	Q9Y3S1
PPVPPPQYFSPAVIL	WNK2	826	Q9Y3S1
TPPQSPPAPPVFLSA	ZNF579	516	Q8NAF0
PFAAPSPFAELVLPP	TYMP	466	P19971
VVNRPPTPPPPYSAF	WBP1L	111	Q9NX94
FADAPPPPSAPNPVV	SF3B4	211	Q15427
PEPPQSSPTPAFPLA	TNS2	1046	Q63HR2
ETFPPFPPPASPERQ	TIPIN	21	Q9BVW5
TAPSPTPSFPGPKPF	ZNF467	341	Q7Z7K2
FTLPPPFPETQPGPL	ZP4	301	Q12836
KFTFPPAALPPPSTP	ZNF804A	1066	Q7Z570
PAYPLEPRFPTAPPT	KMT2D	2181	O14686